These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6445089)

  • 21. [Acrylamide gel electrophoresis and gel filtration as methods of analysis for blood protein derivatives].
    Bosadjiev LG; Bineva I
    Dev Biol Stand; 1974; 27():44-8. PubMed ID: 4142775
    [No Abstract]   [Full Text] [Related]  

  • 22. High-performance affinity chromatography of plasmin and plasminogen on a hydrophilic vinyl-polymer gel coupled with p-aminobenzamidine.
    Shimura K; Kazama M; Kasai K
    J Chromatogr; 1984 Jun; 292(2):369-82. PubMed ID: 6235238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Separation of human Glu-plasminogen, Lys-plasminogen and plasmin by high-performance affinity chromatography on Asahipak GS gel coupled with p-aminobenzamidine.
    Ito N; Noguchi K; Kazama M; Shimura K; Kasai K
    J Chromatogr; 1985 Nov; 348(1):199-204. PubMed ID: 2935552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification of streptokinase by affinity chromatography on immobilized acylated human plasminogen.
    Rodríguez P; Hernàndez L; Muñoz E; Castro A; de la Fuente J; Herrera L
    Biotechniques; 1992 Mar; 12(3):424-9. PubMed ID: 1533307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation, subunit structure, and proteolytic modification of bovine factor VIII.
    Legaz ME; Weinstein MJ; Heldebrant CM; Davie EW
    Ann N Y Acad Sci; 1975 Jan; 240():43-61. PubMed ID: 122888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization and significance of urinary fibrin degradation products.
    Cortes P; Potter EV; Kwaan HC
    J Lab Clin Med; 1973 Sep; 82(3):377-89. PubMed ID: 4199524
    [No Abstract]   [Full Text] [Related]  

  • 27. Physicochemical and biological properties of human and canine plasmins.
    Takeda Y; Nakabayashi M
    J Clin Invest; 1974 Jan; 53(1):154-62. PubMed ID: 4128408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The interaction of human alpha 1-antitrypsin with human plasmin].
    Sakurama S
    Hokkaido Igaku Zasshi; 1984 Jan; 59(1):48-58. PubMed ID: 6232193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Urinary plasmin in late pregnancy toxicosis].
    Katsulov A; Kholevich B; Chernev T
    Akush Ginekol (Sofiia); 1984; 23(5):369-71. PubMed ID: 6240207
    [No Abstract]   [Full Text] [Related]  

  • 30. Selectivity of proteinuria: an evaluation of the immunochemical and gel filtration techniques.
    Pesce AJ; Gaizutis M; Pollak VE
    J Lab Clin Med; 1970 Apr; 75(4):586-606. PubMed ID: 4986371
    [No Abstract]   [Full Text] [Related]  

  • 31. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low molecular weight trypsin-plasmin inhibitors isolated from papain treated urinary trypsin inhibitor.
    Sumi H; Toki N; Takasugi S; Maehara S; Maruyama M; Akazawa K; Matsuo O; Mihara H
    Thromb Haemost; 1982 Feb; 47(1):14-8. PubMed ID: 7071801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demonstration of different D-and E-antigenic intermediates during plasmin degradation of non-stabilized and stabilized fibrin clots.
    Gormsen J; Feddersen C
    Scand J Haematol; 1973; 10(5):337-48. PubMed ID: 4272382
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasminogen-plasmin system. II. Purification and properties of human plasmin.
    Abiko Y; Iwamoto M; Shimizu M
    J Biochem; 1968 Dec; 64(6):751-7. PubMed ID: 4238016
    [No Abstract]   [Full Text] [Related]  

  • 35. FURTHER STUDIES ON THE PURIFICATION AND CHARACTERIZATION OF HUMAN PLASMINOGEN AND PLASMIN.
    ROBBINS KC; SUMMARIA L; ELWYN D; BARLOW GH
    J Biol Chem; 1965 Jan; 240():541-50. PubMed ID: 14253466
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.
    Liotta LA; Goldfarb RH; Brundage R; Siegal GP; Terranova V; Garbisa S
    Cancer Res; 1981 Nov; 41(11 Pt 1):4629-36. PubMed ID: 6458354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation of human immunoglobulin free of plasmin and anticomplement activities.
    Habeeb AF; Francis RD
    Vox Sang; 1977; 32(3):143-58. PubMed ID: 140530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On a plasminogen activator from human plasma.
    Batista AD; Solana GH; Almonte JF
    Thromb Haemost; 1980 Feb; 42(5):1607-14. PubMed ID: 6899948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Complex purification of plasminogen and proteinase inhibitors from blood donors' plasma].
    Zorin NA; Zhabin CG
    Gematol Transfuziol; 1992; 37(9-10):42-3. PubMed ID: 1283376
    [No Abstract]   [Full Text] [Related]  

  • 40. Isolation of a proteinase with plasminogen-activating activity from Lachesis muta muta (bushmaster) snake venom.
    Sanchez EF; Santos CI; Magalhaes A; Diniz CR; Figueiredo S; Gilroy J; Richardson M
    Arch Biochem Biophys; 2000 Jun; 378(1):131-41. PubMed ID: 10871053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.